Corbus Pharmaceuticals Holdings, Inc. Total Long-Term Debt
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Total Long-Term Debt of $17.89 million as of 2023-12-31, per its 10-K filed 2024-03-12.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2024-03-12
- 2023-12-31: Long-term Debt $17.89M.
- 2023-09-30: Long-term Debt $20.03M.
- 2023-06-30: Long-term Debt $20.71M.
- 2023-03-31: Long-term Debt $21.59M.
| Period end | Long-term Debt |
|---|---|
| 2023-12-31 | $17.89M 10-K · filed 2024-03-12 |
| 2023-09-30 | $20.03M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $20.71M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $21.59M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $21.59M 10-K · filed 2023-03-07 |
| 2022-09-30 | $21.19M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $21.19M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $21.19M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $21.19M 10-K · filed 2022-03-08 |
| 2021-09-30 | $21.19M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $21.19M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $21.19M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $21.19M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |